Skip to main content

Share story

Science

UW-Madison catalyst ejects free electrons into solvent, altering photoredox selectivity in Nature study

UW-Madison catalyst ejects free electrons into solvent, altering photoredox selectivity in Nature study Image: Primary
Chemists at the University of Wisconsin-Madison, with collaborators at Colorado State University and the University of Colorado Boulder, report in Nature a catalyst that releases an electron directly into solution rather than handing it to the molecule that is easiest to reduce, ScienceDaily reported. Professor Zachary Wickens said the catalyst ejects the electron into solvent, creating a strong reductant because a free electron will enter almost any molecule rather than remain alone in solution. That can reverse the usual single-electron transfer preference that has limited coupling routes for decades. Colorado collaborators analyzed why the selectivity pattern differs from conventional photoredox design. The work was reported under the title Selectivity Emerges from Indiscriminate Photoreduction, with DOI 10.1038/s41586-026-10897-7.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from ScienceDaily, Nature and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Robotics Capital
Robotics Capital

GenRobot AI raises $100 million for robot training data infrastructure

Beijing-based GenRobot AI has completed a $100 million Series A+ funding round, TechNode reported. The company develops equipment and software that collect human demonstrations for use in training robots, providing data infrastructure for companies developing robots.

AI Infrastructure
AI Infrastructure

Builder runs Kimi K3 on CPU with discontinued Optane memory

A home server builder ran Moonshot AI's 2.8-trillion-parameter Kimi K3 model without a GPU, using discontinued Intel Optane PMem 200 memory and a 40-core Xeon processor, Tom's Hardware reported.

Science
Science

Phase 3 retatrutide trials report weight loss and reduced knee pain

Two Northwestern University-led Phase 3 trials involving more than 1,000 adults found that participants receiving high doses of Eli Lilly's experimental retatrutide lost, on average, up to 25% of their body weight.

AI Products
AI Products

Apple tests development process giving engineers 50% more coding time

Apple is experimenting with a software development process that gives engineers 50% more time to code and explore while reducing time spent on integration, 9to5Mac reported, citing Bloomberg's Mark Gurman. The experiment comes as coding agents have improved.